Entheogens
WHAT’S NEW
Psychedelic Science 2025: Set and (Re)Setting
For its fifth installment, Psychedelic Science 2025 returned to Denver, offering three days of big ideas, heartfelt community, and...
In part one of a series of articles on ibogaine clinics, researcher Leonard Pickard looks at the history and treatment protocols o...
Underscoring an anecdotal observation common among cannabis consumers, a group of researchers in Canada have released a new study ...
POPULAR ARTICLES
Psychedelics: Can they solve the ‘hard problem’ of consciousness? | Matthew Johnson
Can psychedelics solve the ‘hard problem’ of consciousness? Johns Hopkins professor Matthew Johnson explains....
Read More
Recovering the Psychedelic Players from the Margins of History
Rob Dickins, whose new book Cobweb of Trips provides an alternative history of psychedelia, discusses British psychedelic culture,...
Read More
After Latest Clinical Trial, MDMA Therapy For PTSD Is ‘On Track’ For FDA Consideration Next Year
A new peer-reviewed study in the journal Nature says treatment with MDMA reduced symptoms in patients with moderate to severe PTSD...
Read More
New study suggests unique brain mechanisms responsible for psilocybin-induced anxiety
New research shows psilocybin causes anxiety in mice through mechanisms distinct from its psychedelic effects. While ketanserin re...
Read More
Could Psychedelics Be The Future Of Children’s Medicine?
Could LSD, MDMA, and Magic Mushrooms someday help children\'s medicine? George Greer, medical director of the Heffner Institute, t...
Read More
Right to Try: Inside the Psilocybin Lawsuit Against the DEA
The story behind the serious lawsuit currently filed against the DEA....
Read More